Last reviewed · How we verify

NCT03595319

Median Sevoflurane Concentration for Hypotension Between Young and Elderlypatients: Adaptive Clinical Trial

Status unknown Phase 4 Last updated 30 October 2018
What this trial tests

Phase 4 trial testing Sevoflurane in Hypotension in 40 participants. Status unknown.

Timeline
23 July 2018
Primary endpoint
1 October 2018
15 February 2019

Quick facts

Lead sponsorBrasilia University Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingsingle
Primary purposebasic science
Enrollment40
Start date23 July 2018
Primary completion1 October 2018
Estimated completion15 February 2019
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Brasilia University Hospital

Who can join

Adults 19 to 120, any sex, with Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two arms: elder group, young group. Dixon's up and down adaptive methodology for ED50. Executed after Anesthesia induction for 10min without touching the patient after starting mechanical ventilation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

Other recruiting trials for Hypotension

Currently open trials in the same condition.

Other Brasilia University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03595319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing